世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
ボツリヌス免疫診断薬に関する市場調査。農業と食品は引き続き重要な最終用途分野として位置づけられるMarket Study on Botulinum Immunodiagnostics: Agriculture & Food to Remain Prominent End-use Sectors ボツリヌス菌免疫診断薬市場。報告書の範囲 世界のボツリヌス免疫診断薬市場に関するPersistence Market Research社の最新刊は、機会や現在の市場状況を評価し、市場に影響を与える対応するセクションに関する... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーボツリヌス菌免疫診断薬市場。報告書の範囲世界のボツリヌス免疫診断薬市場に関するPersistence Market Research社の最新刊は、機会や現在の市場状況を評価し、市場に影響を与える対応するセクションに関する詳細な分析と最新情報を提供します。この調査は、市場の促進要因、抑制要因、動向、機会を含む現在の市場力学に関する詳細な洞察を提供します。市場調査の主な目的は、市場が2022年から2032年の予測期間中にどのように実行されるかについての排他的な情報を提示することです。 市場の成功成長のための重要な指標は、この包括的なレポートで提示されており、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）など、Persistence Market Research社の調査において網羅的に記述されています。この調査研究は、ボツリヌス免疫診断薬市場の製品やサービスに対する需要、調査期間中の定量的な開発機会を知る上で、読者をサポートすることができます。 この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、ボツリヌス免疫診断薬市場で繁栄するための適切なビジネス戦略の開発に役立てることができます。このPersistence Market Researchの調査で示された洞察と情報は、ボツリヌス免疫診断薬市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家が活用することができる。 市場統計、およびボツリヌス免疫診断薬市場のビジネスシナリオに影響を与えるマクロ経済変数だけでなくミクロ経済変数にリンクされた情報も、現在の研究に含まれています。市場の潜在的な発展に応じて、実質的な洞察はまた、このレポートで遭遇しています。さらに、このレポートで提出されたデータによって、業界のマイナーな企業や新規参入者は、市場での牽引力を達成するために適切な会社の選択を行う際に支援されることができます。 主要な市場セグメント Persistence Market Researchのボツリヌス菌免疫診断市場に関する調査では、製品、アッセイ、目的、用途、エンドユーザー、地域という6つの重要なセグメントに分けられた情報を提供しています。これらのカテゴリに関連する重要な市場力学と成長パラメータに関する包括的なデータと情報を提供しています。 製品 免疫測定キットおよび試薬 キット 一次抗体 二次抗体 免疫測定用基質 免疫測定用バッファー 分析装置・機器 消耗品 ソフトウェア アッセイ ELISA FIA CLIA LFA その他 目的 研究目的のみ 臨床目的 用途 臨床診断薬 創薬 疾患・疾病のスクリーニング エンドユーザー ヘルスケア産業 人体用 獣医 農業・食品産業 地域別 北アメリカ ラテンアメリカ ヨーロッパ 南アジア 東アジア オセアニア 中東・アフリカ 報告書に記載されている主な質問 今後数年間、ボツリヌス菌免疫診断薬で最も収益性の高い市場であり続けるのはどの地域か？ トレンドの変化は市場にどのような影響を与えるのか？ COVID-19危機は市場の成長にどのような影響を与えたか？ 市場参加者はどのようにして先進地域の低空飛行の機会を捉えることができるのか？ 市場におけるステークホルダーの戦略はどのようなものですか？ 投資家が認識する必要があり、市場への投資中に取り組む可能性がある抑制要因は何か？ 市場に影響を与える開発動向は何か？ ボツリヌス免疫診断薬市場の企業は、先進国および新興国での成長機会をどのように利用することができるのか？ 調査方法 Persistence Market Research社の調査では、ボツリヌス免疫診断薬市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論を得るために、独自の調査手法を利用しています。この調査手法は、一次調査と二次調査を組み合わせたもので、これによりアナリストは結論の正確性と信頼性を確保することができる。 市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行いました。 一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、ボツリヌス免疫診断薬市場の成長見通しに関するPersistence Market Researchの予測をより正確で信頼性の高いものにしています。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusion And Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Key Products USP/Feature Analysis 4.2. Regulatory Scenario 4.3. Key Promotional Strategies By Manufacturers 4.4. Recent Product Launches 4.5. Value Chain Analysis 4.6. Product Adoption Analysis, By Region 4.7. PESTEL Analysis 4.8. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Industry Outlook 5.1.3. Immunodiagnostics Market Analysis 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Growing prevalence of Chronic and infectious disease 5.2.3. Growing research and development funding 5.2.4. Increase in research institutes and their activities 5.2.5. Increased Funding and Support from Government 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. 2021 Market Scenario 6.2. COVID-19 and Impact Analysis 6.2.1. By Product 6.2.2. By Assay 6.2.3. By Purpose 6.2.4. By Application 6.2.5. By End User 6.2.6. By Region 7. Global Botulinum Immunodiagnostics Market - Pricing Analysis 7.1. Regional Pricing Analysis, By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Botulinum Immunodiagnostics Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032 8.1. Historical Market Value (US$ Mn) Analysis, 2012–2021 8.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis, By Product, 2012–2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032 9.3.1. Immunoassay Kits & Reagents 9.3.1.1. Kits 9.3.1.2. Primary Antibodies 9.3.1.3. Secondary Antibodies 9.3.1.4. Immunoassay Substrates 9.3.1.5. Immunoassay Buffers 9.3.2. Analyzers & Instrument 9.3.3. Consumables 9.3.4. Software 9.4. Market Attractiveness Analysis, By Product 10. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Assay 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Analysis, By Assay, 2012–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Assay, 2022–2032 10.3.1. ELISA 10.3.2. FIA 10.3.3. CLIA 10.3.4. LFA 10.3.5. Others 10.4. Market Attractiveness Analysis, By Assay 11. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Purpose 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) and Analysis, By Purpose , 2012–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Purpose, 2022–2032 11.3.1. Research Use Only 11.3.2. Clinical Use 11.4. Market Attractiveness Analysis, By Purpose 12. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Application 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis, By Application, 2012–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032 12.3.1. Clinical Diagnostics 12.3.2. Drug Discovery 12.3.3. Screening of Diseases & Disorders 12.4. Market Attractiveness Analysis, By Application 13. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By End User 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Analysis, By End User, 2012–2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 13.3.1. Healthcare Industry 13.3.1.1. Human Use 13.3.1.2. Veterinary 13.3.2. Agriculture & Food Industry 13.4. Market Attractiveness Analysis, By End User 14. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Region 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Analysis, By Region, 2012–2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032 14.3.1. North America 14.3.2. Latin America 14.3.3. Europe 14.3.4. South Asia 14.3.5. East Asia 14.3.6. Oceania 14.3.7. Middle East and Africa 14.4. Market Attractiveness Analysis, By Region 15. North America Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 15.3.1. By Country 15.3.1.1. U.S. 15.3.1.2. Canada 15.3.2. By Product 15.3.3. By Assay 15.3.4. By Purpose 15.3.5. By Application 15.3.6. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Assay 15.4.4. By Purpose 15.4.5. By Application 15.4.6. By End User 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 15.7. Key Market Trends 15.8. Country Level Analysis & Forecast 15.8.1. U.S. Botulinum Immunodiagnostics Market 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Assay 15.8.1.2.3. By Purpose 15.8.1.2.4. By Application 15.8.1.2.5. By End User 15.8.2. Canada Botulinum Immunodiagnostics Market 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By Assay 15.8.2.2.3. By Purpose 15.8.2.2.4. By Application 15.8.2.2.5. By End User 16. Latin America Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 16.3.1. By Country 16.3.1.1. Brazil 16.3.1.2. Argentina 16.3.1.3. Mexico 16.3.1.4. Rest of Latin America 16.3.2. By Product 16.3.3. By Assay 16.3.4. By Purpose 16.3.5. By Application 16.3.6. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Assay 16.4.4. By Purpose 16.4.5. By Application 16.4.6. By End User 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 16.7. Key Market Trends 16.8. Country Level Analysis & Forecast 16.8.1. Brazil Botulinum Immunodiagnostics Market 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Assay 16.8.1.2.3. By Purpose 16.8.1.2.4. By Application 16.8.1.2.5. By End User 16.8.2. Argentina Botulinum Immunodiagnostics Market 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Assay 16.8.2.2.3. By Purpose 16.8.2.2.4. By Application 16.8.2.2.5. By End User 16.8.3. Mexico Botulinum Immunodiagnostics Market 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Assay 16.8.3.2.3. By Purpose 16.8.3.2.4. By Application 16.8.3.2.5. By End User 17. Europe Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 17.3.1. By Country 17.3.1.1. Germany 17.3.1.2. Italy 17.3.1.3. France 17.3.1.4. U.K. 17.3.1.5. Spain 17.3.1.6. BENELUX 17.3.1.7. Nordic Countries 17.3.1.8. Russia 17.3.1.9. Rest of Europe 17.3.2. By Product 17.3.3. By Assay 17.3.4. By Purpose 17.3.5. By Application 17.3.6. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Assay 17.4.4. By Purpose 17.4.5. By Application 17.4.6. By End User 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 17.7. Key Market Trends 17.8. Country Level Analysis & Forecast 17.8.1. Germany Botulinum Immunodiagnostics Market 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Assay 17.8.1.2.3. By Purpose 17.8.1.2.4. By Application 17.8.1.2.5. By End User 17.8.2. France Botulinum Immunodiagnostics Market 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Assay 17.8.2.2.3. By Purpose 17.8.2.2.4. By Application 17.8.2.2.5. By End User 17.8.3. Italy Botulinum Immunodiagnostics Market 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Assay 17.8.3.2.3. By Purpose 17.8.3.2.4. By Application 17.8.3.2.5. By End User 17.8.4. Spain Botulinum Immunodiagnostics Market 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product 17.8.4.2.2. By Assay 17.8.4.2.3. By Purpose 17.8.4.2.4. By Application 17.8.4.2.5. By End User 17.8.5. U.K. Botulinum Immunodiagnostics Market 17.8.5.1. Introduction 17.8.5.2. Market Analysis and Forecast by Market Taxonomy 17.8.5.2.1. By Product 17.8.5.2.2. By Assay 17.8.5.2.3. By Purpose 17.8.5.2.4. By Application 17.8.5.2.5. By End User 17.8.6. BENELUX Botulinum Immunodiagnostics Market 17.8.6.1. Introduction 17.8.6.2. Market Analysis and Forecast by Market Taxonomy 17.8.6.2.1. By Product 17.8.6.2.2. By Assay 17.8.6.2.3. By Purpose 17.8.6.2.4. By Application 17.8.6.2.5. By End User 17.8.7. Nordic Countries Botulinum Immunodiagnostics Market 17.8.7.1. Introduction 17.8.7.2. Market Analysis and Forecast by Market Taxonomy 17.8.7.2.1. By Product 17.8.7.2.2. By Assay 17.8.7.2.3. By Purpose 17.8.7.2.4. By Application 17.8.7.2.5. By End User 17.8.8. Russia Botulinum Immunodiagnostics Market 17.8.8.1. Introduction 17.8.8.2. Market Analysis and Forecast by Market Taxonomy 17.8.8.2.1. By Product 17.8.8.2.2. By Assay 17.8.8.2.3. By Purpose 17.8.8.2.4. By Application 17.8.8.2.5. By End User 18. South Asia Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 18.3.1. By Country 18.3.1.1. India 18.3.1.2. Thailand 18.3.1.3. Indonesia 18.3.1.4. Malaysia 18.3.1.5. Philippines 18.3.1.6. Vietnam 18.3.1.7. Rest of South Asia 18.3.2. By Product 18.3.3. By Assay 18.3.4. By Purpose 18.3.5. By Application 18.3.6. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Assay 18.4.4. By Purpose 18.4.5. By Application 18.4.6. By End User 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 18.7. Key Market Trends 18.8. Country Level Analysis & Forecast 18.8.1. India Botulinum Immunodiagnostics Market 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Assay 18.8.1.2.3. By Purpose 18.8.1.2.4. By Application 18.8.1.2.5. By End User 18.8.2. Indonesia Botulinum Immunodiagnostics Market 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Assay 18.8.2.2.3. By Purpose 18.8.2.2.4. By Application 18.8.2.2.5. By End User 18.8.3. Malaysia Botulinum Immunodiagnostics Market 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Product 18.8.3.2.2. By Assay 18.8.3.2.3. By Purpose 18.8.3.2.4. By Application 18.8.3.2.5. By End User 18.8.4. Philippines Botulinum Immunodiagnostics Market 18.8.4.1. Introduction 18.8.4.2. Market Analysis and Forecast by Market Taxonomy 18.8.4.2.1. By Product 18.8.4.2.2. By Assay 18.8.4.2.3. By Purpose 18.8.4.2.4. By Application 18.8.4.2.5. By End User 18.8.5. Thailand Botulinum Immunodiagnostics Market 18.8.5.1. Introduction 18.8.5.2. Market Analysis and Forecast by Market Taxonomy 18.8.5.2.1. By Product 18.8.5.2.2. By Assay 18.8.5.2.3. By Purpose 18.8.5.2.4. By Application 18.8.5.2.5. By End User 18.8.6. Vietnam Botulinum Immunodiagnostics Market 18.8.6.1. Introduction 18.8.6.2. Market Analysis and Forecast by Market Taxonomy 18.8.6.2.1. By Product 18.8.6.2.2. By Assay 18.8.6.2.3. By Purpose 18.8.6.2.4. By Application 18.8.6.2.5. By End User 19. East Asia (Excluding Hong Kong) Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 19.3.1. By Country 19.3.1.1. China 19.3.1.2. Japan 19.3.1.3. South Korea 19.3.2. By Product 19.3.3. By Assay 19.3.4. By Purpose 19.3.5. By Application 19.3.6. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Assay 19.4.4. By Purpose 19.4.5. By Application 19.4.6. By End User 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 19.7. Key Market Trends 19.8. Country Level Analysis & Forecast 19.8.1. China Botulinum Immunodiagnostics Market 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Assay 19.8.1.2.3. By Purpose 19.8.1.2.4. By Application 19.8.1.2.5. By End User 19.8.2. Japan Botulinum Immunodiagnostics Market 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Assay 19.8.2.2.3. By Purpose 19.8.2.2.4. By Application 19.8.2.2.5. By End User 19.8.3. South Korea Botulinum Immunodiagnostics Market 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Assay 19.8.3.2.3. By Purpose 19.8.3.2.4. By Application 19.8.3.2.5. By End User 20. Oceania Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 20.1. Introduction 20.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 20.3.1. By Country 20.3.1.1. Australia 20.3.1.2. New Zealand 20.3.2. By Product 20.3.3. By Assay 20.3.4. By Purpose 20.3.5. By Application 20.3.6. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Assay 20.4.4. By Purpose 20.4.5. By Application 20.4.6. By End User 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 20.7. Key Market Trends 20.8. Country Level Analysis & Forecast 20.8.1. Australia Botulinum Immunodiagnostics Market 20.8.1.1. Introduction 20.8.1.2. Market Analysis and Forecast by Market Taxonomy 20.8.1.2.1. By Product 20.8.1.2.2. By Assay 20.8.1.2.3. By Purpose 20.8.1.2.4. By Application 20.8.1.2.5. By End User 20.8.2. New Zealand Botulinum Immunodiagnostics Market 20.8.2.1. Introduction 20.8.2.2. Market Analysis and Forecast by Market Taxonomy 20.8.2.2.1. By Product 20.8.2.2.2. By Assay 20.8.2.2.3. By Purpose 20.8.2.2.4. By Application 20.8.2.2.5. By End User 21. Middle East and Africa (MEA) Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 21.1. Introduction 21.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 21.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 21.3.1. By Country 21.3.1.1. GCC Countries 21.3.1.2. Turkey 21.3.1.3. Israel 21.3.1.4. Egypt 21.3.1.5. North Africa 21.3.1.6. South Africa 21.3.1.7. Rest of Middle East and Africa 21.3.2. By Product 21.3.3. By Assay 21.3.4. By Purpose 21.3.5. By Application 21.3.6. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Product 21.4.3. By Assay 21.4.4. By Purpose 21.4.5. By Application 21.4.6. By End User 21.5. Key Market Participants - Intensity Mapping 21.6. Drivers and Restraints - Impact Analysis 21.7. Key Market Trends 21.8. Country Level Analysis & Forecast 21.8.1. GCC Countries Botulinum Immunodiagnostics Market 21.8.1.1. Introduction 21.8.1.2. Market Analysis and Forecast by Market Taxonomy 21.8.1.2.1. By Product 21.8.1.2.2. By Assay 21.8.1.2.3. By Purpose 21.8.1.2.4. By Application 21.8.1.2.5. By End User 21.8.2. Egypt Botulinum Immunodiagnostics Market 21.8.2.1. Introduction 21.8.2.2. Market Analysis and Forecast by Market Taxonomy 21.8.2.2.1. By Product 21.8.2.2.2. By Assay 21.8.2.2.3. By Purpose 21.8.2.2.4. By Application 21.8.2.2.5. By End User 21.8.3. Turkey Botulinum Immunodiagnostics Market 21.8.3.1. Introduction 21.8.3.2. Market Analysis and Forecast by Market Taxonomy 21.8.3.2.1. By Product 21.8.3.2.2. By Assay 21.8.3.2.3. By Purpose 21.8.3.2.4. By Application 21.8.3.2.5. By End User 21.8.4. Israel Botulinum Immunodiagnostics Market 21.8.4.1. Introduction 21.8.4.2. Market Analysis and Forecast by Market Taxonomy 21.8.4.2.1. By Product 21.8.4.2.2. By Assay 21.8.4.2.3. By Purpose 21.8.4.2.4. By Application 21.8.4.2.5. By End User 21.8.5. South Africa Botulinum Immunodiagnostics Market 21.8.5.1. Introduction 21.8.5.2. Market Analysis and Forecast by Market Taxonomy 21.8.5.2.1. By Product 21.8.5.2.2. By Assay 21.8.5.2.3. By Purpose 21.8.5.2.4. By Application 21.8.5.2.5. By End User 21.8.6. North Africa Botulinum Immunodiagnostics Market 21.8.6.1. Introduction 21.8.6.2. Market Analysis and Forecast by Market Taxonomy 21.8.6.2.1. By Product 21.8.6.2.2. By Assay 21.8.6.2.3. By Purpose 21.8.6.2.4. By Application 21.8.6.2.5. By End User 22. Market Structure Analysis 22.1. Market Analysis, By Tier of Companies 22.2. Market Share Analysis of Top Players 22.3. Market Presence Analysis 22.3.1. Regional footprint of Players 22.3.2. Product foot print by Players 22.3.3. Channel Foot Print by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Competition Deep Dive 23.3.1. BioCheck (BIOTECON Diagnostics). 23.3.1.1. Company Overview 23.3.1.2. Product Portfolio 23.3.1.3. Sales Footprint 23.3.1.4. Key Financials 23.3.1.5. SWOT Analysis 23.3.1.6. Key Developments 23.3.1.7. Strategy Overview 23.3.1.7.1. Channel Strategy 23.3.1.7.2. Marketing Strategy 23.3.1.7.3. Product Strategy 23.3.2. AdVnt Biotechnologies 23.3.2.1. Company Overview 23.3.2.2. Product Portfolio 23.3.2.3. Sales Footprint 23.3.2.4. Key Financials 23.3.2.5. SWOT Analysis 23.3.2.6. Key Developments 23.3.2.7. Strategy Overview 23.3.2.7.1. Channel Strategy 23.3.2.7.2. Marketing Strategy 23.3.2.7.3. Product Strategy 23.3.3. ThermoFisher Scientific 23.3.3.1. Company Overview 23.3.3.2. Product Portfolio 23.3.3.3. Sales Footprint 23.3.3.4. Key Financials 23.3.3.5. SWOT Analysis 23.3.3.6. Key Developments 23.3.3.7. Strategy Overview 23.3.3.7.1. Channel Strategy 23.3.3.7.2. Marketing Strategy 23.3.3.7.3. Product Strategy 23.3.4. Bio-Techne. 23.3.4.1. Company Overview 23.3.4.2. Product Portfolio 23.3.4.3. Sales Footprint 23.3.4.4. Key Financials 23.3.4.5. SWOT Analysis 23.3.4.6. Key Developments 23.3.4.7. Strategy Overview 23.3.4.7.1. Channel Strategy 23.3.4.7.2. Marketing Strategy 23.3.4.7.3. Product Strategy 23.3.5. Response Biomedical 23.3.5.1. Company Overview 23.3.5.2. Product Portfolio 23.3.5.3. Sales Footprint 23.3.5.4. Key Financials 23.3.5.5. SWOT Analysis 23.3.5.6. Key Developments 23.3.5.7. Strategy Overview 23.3.5.7.1. Channel Strategy 23.3.5.7.2. Marketing Strategy 23.3.5.7.3. Product Strategy 23.3.6. New Horizons Diagnostic Corporation 23.3.6.1. Company Overview 23.3.6.2. Product Portfolio 23.3.6.3. Sales Footprint 23.3.6.4. Key Financials 23.3.6.5. SWOT Analysis 23.3.6.6. Key Developments 23.3.6.7. Strategy Overview 23.3.6.7.1. Channel Strategy 23.3.6.7.2. Marketing Strategy 23.3.6.7.3. Product Strategy 23.3.7. Bio-Rad Laboratories 23.3.7.1. Company Overview 23.3.7.2. Product Portfolio 23.3.7.3. Sales Footprint 23.3.7.4. Key Financials 23.3.7.5. SWOT Analysis 23.3.7.6. Key Developments 23.3.7.7. Strategy Overview 23.3.7.7.1. Channel Strategy 23.3.7.7.2. Marketing Strategy 23.3.7.7.3. Product Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
SummaryBotulinum Immunodiagnostics Market: Report Scope Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusion And Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Key Products USP/Feature Analysis 4.2. Regulatory Scenario 4.3. Key Promotional Strategies By Manufacturers 4.4. Recent Product Launches 4.5. Value Chain Analysis 4.6. Product Adoption Analysis, By Region 4.7. PESTEL Analysis 4.8. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Industry Outlook 5.1.3. Immunodiagnostics Market Analysis 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Growing prevalence of Chronic and infectious disease 5.2.3. Growing research and development funding 5.2.4. Increase in research institutes and their activities 5.2.5. Increased Funding and Support from Government 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. 2021 Market Scenario 6.2. COVID-19 and Impact Analysis 6.2.1. By Product 6.2.2. By Assay 6.2.3. By Purpose 6.2.4. By Application 6.2.5. By End User 6.2.6. By Region 7. Global Botulinum Immunodiagnostics Market - Pricing Analysis 7.1. Regional Pricing Analysis, By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Botulinum Immunodiagnostics Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032 8.1. Historical Market Value (US$ Mn) Analysis, 2012–2021 8.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis, By Product, 2012–2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032 9.3.1. Immunoassay Kits & Reagents 9.3.1.1. Kits 9.3.1.2. Primary Antibodies 9.3.1.3. Secondary Antibodies 9.3.1.4. Immunoassay Substrates 9.3.1.5. Immunoassay Buffers 9.3.2. Analyzers & Instrument 9.3.3. Consumables 9.3.4. Software 9.4. Market Attractiveness Analysis, By Product 10. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Assay 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Analysis, By Assay, 2012–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Assay, 2022–2032 10.3.1. ELISA 10.3.2. FIA 10.3.3. CLIA 10.3.4. LFA 10.3.5. Others 10.4. Market Attractiveness Analysis, By Assay 11. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Purpose 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) and Analysis, By Purpose , 2012–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Purpose, 2022–2032 11.3.1. Research Use Only 11.3.2. Clinical Use 11.4. Market Attractiveness Analysis, By Purpose 12. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Application 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis, By Application, 2012–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032 12.3.1. Clinical Diagnostics 12.3.2. Drug Discovery 12.3.3. Screening of Diseases & Disorders 12.4. Market Attractiveness Analysis, By Application 13. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By End User 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Analysis, By End User, 2012–2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 13.3.1. Healthcare Industry 13.3.1.1. Human Use 13.3.1.2. Veterinary 13.3.2. Agriculture & Food Industry 13.4. Market Attractiveness Analysis, By End User 14. Global Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032, By Region 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Analysis, By Region, 2012–2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032 14.3.1. North America 14.3.2. Latin America 14.3.3. Europe 14.3.4. South Asia 14.3.5. East Asia 14.3.6. Oceania 14.3.7. Middle East and Africa 14.4. Market Attractiveness Analysis, By Region 15. North America Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 15.3.1. By Country 15.3.1.1. U.S. 15.3.1.2. Canada 15.3.2. By Product 15.3.3. By Assay 15.3.4. By Purpose 15.3.5. By Application 15.3.6. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Assay 15.4.4. By Purpose 15.4.5. By Application 15.4.6. By End User 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 15.7. Key Market Trends 15.8. Country Level Analysis & Forecast 15.8.1. U.S. Botulinum Immunodiagnostics Market 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Assay 15.8.1.2.3. By Purpose 15.8.1.2.4. By Application 15.8.1.2.5. By End User 15.8.2. Canada Botulinum Immunodiagnostics Market 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By Assay 15.8.2.2.3. By Purpose 15.8.2.2.4. By Application 15.8.2.2.5. By End User 16. Latin America Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 16.3.1. By Country 16.3.1.1. Brazil 16.3.1.2. Argentina 16.3.1.3. Mexico 16.3.1.4. Rest of Latin America 16.3.2. By Product 16.3.3. By Assay 16.3.4. By Purpose 16.3.5. By Application 16.3.6. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Assay 16.4.4. By Purpose 16.4.5. By Application 16.4.6. By End User 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 16.7. Key Market Trends 16.8. Country Level Analysis & Forecast 16.8.1. Brazil Botulinum Immunodiagnostics Market 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Assay 16.8.1.2.3. By Purpose 16.8.1.2.4. By Application 16.8.1.2.5. By End User 16.8.2. Argentina Botulinum Immunodiagnostics Market 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Assay 16.8.2.2.3. By Purpose 16.8.2.2.4. By Application 16.8.2.2.5. By End User 16.8.3. Mexico Botulinum Immunodiagnostics Market 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Assay 16.8.3.2.3. By Purpose 16.8.3.2.4. By Application 16.8.3.2.5. By End User 17. Europe Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 17.3.1. By Country 17.3.1.1. Germany 17.3.1.2. Italy 17.3.1.3. France 17.3.1.4. U.K. 17.3.1.5. Spain 17.3.1.6. BENELUX 17.3.1.7. Nordic Countries 17.3.1.8. Russia 17.3.1.9. Rest of Europe 17.3.2. By Product 17.3.3. By Assay 17.3.4. By Purpose 17.3.5. By Application 17.3.6. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Assay 17.4.4. By Purpose 17.4.5. By Application 17.4.6. By End User 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 17.7. Key Market Trends 17.8. Country Level Analysis & Forecast 17.8.1. Germany Botulinum Immunodiagnostics Market 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Assay 17.8.1.2.3. By Purpose 17.8.1.2.4. By Application 17.8.1.2.5. By End User 17.8.2. France Botulinum Immunodiagnostics Market 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Assay 17.8.2.2.3. By Purpose 17.8.2.2.4. By Application 17.8.2.2.5. By End User 17.8.3. Italy Botulinum Immunodiagnostics Market 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Assay 17.8.3.2.3. By Purpose 17.8.3.2.4. By Application 17.8.3.2.5. By End User 17.8.4. Spain Botulinum Immunodiagnostics Market 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product 17.8.4.2.2. By Assay 17.8.4.2.3. By Purpose 17.8.4.2.4. By Application 17.8.4.2.5. By End User 17.8.5. U.K. Botulinum Immunodiagnostics Market 17.8.5.1. Introduction 17.8.5.2. Market Analysis and Forecast by Market Taxonomy 17.8.5.2.1. By Product 17.8.5.2.2. By Assay 17.8.5.2.3. By Purpose 17.8.5.2.4. By Application 17.8.5.2.5. By End User 17.8.6. BENELUX Botulinum Immunodiagnostics Market 17.8.6.1. Introduction 17.8.6.2. Market Analysis and Forecast by Market Taxonomy 17.8.6.2.1. By Product 17.8.6.2.2. By Assay 17.8.6.2.3. By Purpose 17.8.6.2.4. By Application 17.8.6.2.5. By End User 17.8.7. Nordic Countries Botulinum Immunodiagnostics Market 17.8.7.1. Introduction 17.8.7.2. Market Analysis and Forecast by Market Taxonomy 17.8.7.2.1. By Product 17.8.7.2.2. By Assay 17.8.7.2.3. By Purpose 17.8.7.2.4. By Application 17.8.7.2.5. By End User 17.8.8. Russia Botulinum Immunodiagnostics Market 17.8.8.1. Introduction 17.8.8.2. Market Analysis and Forecast by Market Taxonomy 17.8.8.2.1. By Product 17.8.8.2.2. By Assay 17.8.8.2.3. By Purpose 17.8.8.2.4. By Application 17.8.8.2.5. By End User 18. South Asia Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 18.3.1. By Country 18.3.1.1. India 18.3.1.2. Thailand 18.3.1.3. Indonesia 18.3.1.4. Malaysia 18.3.1.5. Philippines 18.3.1.6. Vietnam 18.3.1.7. Rest of South Asia 18.3.2. By Product 18.3.3. By Assay 18.3.4. By Purpose 18.3.5. By Application 18.3.6. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Assay 18.4.4. By Purpose 18.4.5. By Application 18.4.6. By End User 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 18.7. Key Market Trends 18.8. Country Level Analysis & Forecast 18.8.1. India Botulinum Immunodiagnostics Market 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Assay 18.8.1.2.3. By Purpose 18.8.1.2.4. By Application 18.8.1.2.5. By End User 18.8.2. Indonesia Botulinum Immunodiagnostics Market 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Assay 18.8.2.2.3. By Purpose 18.8.2.2.4. By Application 18.8.2.2.5. By End User 18.8.3. Malaysia Botulinum Immunodiagnostics Market 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Product 18.8.3.2.2. By Assay 18.8.3.2.3. By Purpose 18.8.3.2.4. By Application 18.8.3.2.5. By End User 18.8.4. Philippines Botulinum Immunodiagnostics Market 18.8.4.1. Introduction 18.8.4.2. Market Analysis and Forecast by Market Taxonomy 18.8.4.2.1. By Product 18.8.4.2.2. By Assay 18.8.4.2.3. By Purpose 18.8.4.2.4. By Application 18.8.4.2.5. By End User 18.8.5. Thailand Botulinum Immunodiagnostics Market 18.8.5.1. Introduction 18.8.5.2. Market Analysis and Forecast by Market Taxonomy 18.8.5.2.1. By Product 18.8.5.2.2. By Assay 18.8.5.2.3. By Purpose 18.8.5.2.4. By Application 18.8.5.2.5. By End User 18.8.6. Vietnam Botulinum Immunodiagnostics Market 18.8.6.1. Introduction 18.8.6.2. Market Analysis and Forecast by Market Taxonomy 18.8.6.2.1. By Product 18.8.6.2.2. By Assay 18.8.6.2.3. By Purpose 18.8.6.2.4. By Application 18.8.6.2.5. By End User 19. East Asia (Excluding Hong Kong) Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 19.3.1. By Country 19.3.1.1. China 19.3.1.2. Japan 19.3.1.3. South Korea 19.3.2. By Product 19.3.3. By Assay 19.3.4. By Purpose 19.3.5. By Application 19.3.6. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Assay 19.4.4. By Purpose 19.4.5. By Application 19.4.6. By End User 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 19.7. Key Market Trends 19.8. Country Level Analysis & Forecast 19.8.1. China Botulinum Immunodiagnostics Market 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Assay 19.8.1.2.3. By Purpose 19.8.1.2.4. By Application 19.8.1.2.5. By End User 19.8.2. Japan Botulinum Immunodiagnostics Market 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Assay 19.8.2.2.3. By Purpose 19.8.2.2.4. By Application 19.8.2.2.5. By End User 19.8.3. South Korea Botulinum Immunodiagnostics Market 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Assay 19.8.3.2.3. By Purpose 19.8.3.2.4. By Application 19.8.3.2.5. By End User 20. Oceania Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 20.1. Introduction 20.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 20.3.1. By Country 20.3.1.1. Australia 20.3.1.2. New Zealand 20.3.2. By Product 20.3.3. By Assay 20.3.4. By Purpose 20.3.5. By Application 20.3.6. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Assay 20.4.4. By Purpose 20.4.5. By Application 20.4.6. By End User 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 20.7. Key Market Trends 20.8. Country Level Analysis & Forecast 20.8.1. Australia Botulinum Immunodiagnostics Market 20.8.1.1. Introduction 20.8.1.2. Market Analysis and Forecast by Market Taxonomy 20.8.1.2.1. By Product 20.8.1.2.2. By Assay 20.8.1.2.3. By Purpose 20.8.1.2.4. By Application 20.8.1.2.5. By End User 20.8.2. New Zealand Botulinum Immunodiagnostics Market 20.8.2.1. Introduction 20.8.2.2. Market Analysis and Forecast by Market Taxonomy 20.8.2.2.1. By Product 20.8.2.2.2. By Assay 20.8.2.2.3. By Purpose 20.8.2.2.4. By Application 20.8.2.2.5. By End User 21. Middle East and Africa (MEA) Botulinum Immunodiagnostics Market Analysis 2012–2021 and Forecast 2022–2032 21.1. Introduction 21.2. Historical Market Size (US$ Mn) Analysis, By Market Taxonomy, 2012–2021 21.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2032 21.3.1. By Country 21.3.1.1. GCC Countries 21.3.1.2. Turkey 21.3.1.3. Israel 21.3.1.4. Egypt 21.3.1.5. North Africa 21.3.1.6. South Africa 21.3.1.7. Rest of Middle East and Africa 21.3.2. By Product 21.3.3. By Assay 21.3.4. By Purpose 21.3.5. By Application 21.3.6. By End User 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Product 21.4.3. By Assay 21.4.4. By Purpose 21.4.5. By Application 21.4.6. By End User 21.5. Key Market Participants - Intensity Mapping 21.6. Drivers and Restraints - Impact Analysis 21.7. Key Market Trends 21.8. Country Level Analysis & Forecast 21.8.1. GCC Countries Botulinum Immunodiagnostics Market 21.8.1.1. Introduction 21.8.1.2. Market Analysis and Forecast by Market Taxonomy 21.8.1.2.1. By Product 21.8.1.2.2. By Assay 21.8.1.2.3. By Purpose 21.8.1.2.4. By Application 21.8.1.2.5. By End User 21.8.2. Egypt Botulinum Immunodiagnostics Market 21.8.2.1. Introduction 21.8.2.2. Market Analysis and Forecast by Market Taxonomy 21.8.2.2.1. By Product 21.8.2.2.2. By Assay 21.8.2.2.3. By Purpose 21.8.2.2.4. By Application 21.8.2.2.5. By End User 21.8.3. Turkey Botulinum Immunodiagnostics Market 21.8.3.1. Introduction 21.8.3.2. Market Analysis and Forecast by Market Taxonomy 21.8.3.2.1. By Product 21.8.3.2.2. By Assay 21.8.3.2.3. By Purpose 21.8.3.2.4. By Application 21.8.3.2.5. By End User 21.8.4. Israel Botulinum Immunodiagnostics Market 21.8.4.1. Introduction 21.8.4.2. Market Analysis and Forecast by Market Taxonomy 21.8.4.2.1. By Product 21.8.4.2.2. By Assay 21.8.4.2.3. By Purpose 21.8.4.2.4. By Application 21.8.4.2.5. By End User 21.8.5. South Africa Botulinum Immunodiagnostics Market 21.8.5.1. Introduction 21.8.5.2. Market Analysis and Forecast by Market Taxonomy 21.8.5.2.1. By Product 21.8.5.2.2. By Assay 21.8.5.2.3. By Purpose 21.8.5.2.4. By Application 21.8.5.2.5. By End User 21.8.6. North Africa Botulinum Immunodiagnostics Market 21.8.6.1. Introduction 21.8.6.2. Market Analysis and Forecast by Market Taxonomy 21.8.6.2.1. By Product 21.8.6.2.2. By Assay 21.8.6.2.3. By Purpose 21.8.6.2.4. By Application 21.8.6.2.5. By End User 22. Market Structure Analysis 22.1. Market Analysis, By Tier of Companies 22.2. Market Share Analysis of Top Players 22.3. Market Presence Analysis 22.3.1. Regional footprint of Players 22.3.2. Product foot print by Players 22.3.3. Channel Foot Print by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Competition Deep Dive 23.3.1. BioCheck (BIOTECON Diagnostics). 23.3.1.1. Company Overview 23.3.1.2. Product Portfolio 23.3.1.3. Sales Footprint 23.3.1.4. Key Financials 23.3.1.5. SWOT Analysis 23.3.1.6. Key Developments 23.3.1.7. Strategy Overview 23.3.1.7.1. Channel Strategy 23.3.1.7.2. Marketing Strategy 23.3.1.7.3. Product Strategy 23.3.2. AdVnt Biotechnologies 23.3.2.1. Company Overview 23.3.2.2. Product Portfolio 23.3.2.3. Sales Footprint 23.3.2.4. Key Financials 23.3.2.5. SWOT Analysis 23.3.2.6. Key Developments 23.3.2.7. Strategy Overview 23.3.2.7.1. Channel Strategy 23.3.2.7.2. Marketing Strategy 23.3.2.7.3. Product Strategy 23.3.3. ThermoFisher Scientific 23.3.3.1. Company Overview 23.3.3.2. Product Portfolio 23.3.3.3. Sales Footprint 23.3.3.4. Key Financials 23.3.3.5. SWOT Analysis 23.3.3.6. Key Developments 23.3.3.7. Strategy Overview 23.3.3.7.1. Channel Strategy 23.3.3.7.2. Marketing Strategy 23.3.3.7.3. Product Strategy 23.3.4. Bio-Techne. 23.3.4.1. Company Overview 23.3.4.2. Product Portfolio 23.3.4.3. Sales Footprint 23.3.4.4. Key Financials 23.3.4.5. SWOT Analysis 23.3.4.6. Key Developments 23.3.4.7. Strategy Overview 23.3.4.7.1. Channel Strategy 23.3.4.7.2. Marketing Strategy 23.3.4.7.3. Product Strategy 23.3.5. Response Biomedical 23.3.5.1. Company Overview 23.3.5.2. Product Portfolio 23.3.5.3. Sales Footprint 23.3.5.4. Key Financials 23.3.5.5. SWOT Analysis 23.3.5.6. Key Developments 23.3.5.7. Strategy Overview 23.3.5.7.1. Channel Strategy 23.3.5.7.2. Marketing Strategy 23.3.5.7.3. Product Strategy 23.3.6. New Horizons Diagnostic Corporation 23.3.6.1. Company Overview 23.3.6.2. Product Portfolio 23.3.6.3. Sales Footprint 23.3.6.4. Key Financials 23.3.6.5. SWOT Analysis 23.3.6.6. Key Developments 23.3.6.7. Strategy Overview 23.3.6.7.1. Channel Strategy 23.3.6.7.2. Marketing Strategy 23.3.6.7.3. Product Strategy 23.3.7. Bio-Rad Laboratories 23.3.7.1. Company Overview 23.3.7.2. Product Portfolio 23.3.7.3. Sales Footprint 23.3.7.4. Key Financials 23.3.7.5. SWOT Analysis 23.3.7.6. Key Developments 23.3.7.7. Strategy Overview 23.3.7.7.1. Channel Strategy 23.3.7.7.2. Marketing Strategy 23.3.7.7.3. Product Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（農業）の最新刊レポート
Persistence Market Research社の農業分野での最新刊レポート
本レポートと同じKEY WORD（agriculture）の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
